Nano Precision Medical
Biopharmaceutical company with varied pipeline. Merger planned with Second Sight 2022.
Nano Precision Medical. Inc is a privately held biopharmaceutical company developing drug implants by leveraging the company’s proprietary NanoPortal drug implant technology. These drug implants, designed to deliver minimally fluctuating drug profiles, will address drug non-adherence which is one of the top reasons for sub-optimal clinical benefit associated with oral and injectable products that treat chronic disease.
The company’s lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes.
The Company’s headquarters are in Emeryville, California.
Visit website: https://www.nanoprecisionmedical.com/
Nano Precision Medical News
Lights go off for people with obsolete Second Sight retinal implants
BBC - 17-Feb-2022
No promised upgrades, and no vision at all for some recipientsRead more...